z-logo
open-access-imgOpen Access
Structure of Mycobacterium tuberculosis glutamine synthetase in complex with a transition-state mimic provides functional insights
Author(s) -
Wojciech Krajewski,
T. Alwyn Jones,
Sherry L. Mowbray
Publication year - 2005
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.0502248102
Subject(s) - glutamine synthetase , enzyme , biochemistry , transition state analog , glutamine , glutamine amidotransferase , active site , chemistry , mycobacterium tuberculosis , biology , tuberculosis , amino acid , medicine , pathology
Glutamine synthetase catalyzes the ligation of glutamate and ammonia to form glutamine, with the resulting hydrolysis of ATP. The enzyme is a central component of bacterial nitrogen metabolism and is a potential drug target. Here, we report a high-yield recombinant expression system for glutamine synthetase of Mycobacterium tuberculosis together with a simple purification. The procedure allowed the structure of a complex with a phosphorylated form of the inhibitor methionine sulfoximine, magnesium, and ADP to be solved by molecular replacement and refined at 2.1-A resolution. To our knowledge, this study provides the first reported structure for a taut form of the M. tuberculosis enzyme, similar to that observed for the Salmonella enzyme earlier. The phospho compound, generated in situ by an active enzyme, mimics the phosphorylated tetrahedral adduct at the transition state. Some differences in ligand interactions of the protein with both phosphorylated compound and nucleotide are observed compared with earlier structures; a third metal ion also is found. The importance of these differences in the catalytic mechanism is discussed; the results will help guide the search for specific inhibitors of potential therapeutic interest.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here